Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons

The electrophysiological, biochemical and behavioral responses produced by administration of haloperidol were studied in intact rats and in rats with 6-hydroxydopamine-induced partial lesions of the nigrostriatal dopamine pathway. In both control rats and rates tested four to 10 days postlesion, the electrophysiological response of nigral dopamine neurons to increasing doses of haloperidol consisted of either: (1) an increase in firing rate which reached a plateau at six to 10 spikes per second, or (2) no response (i.e., less than 20% change in firing rate). Administration of additional doses of haloperidol up to lethal levels did not elicit further changes in dopamine cell firing in these rats. In contrast, in 6-hydroxydopamine-treated rats tested four to six weeks postlesion, acute administration of haloperidol was not only more consistent in producing increases in dopamine cell firing rate, but also caused six out of seven dopamine neurons tested to cease firing upon entering a state of depolarization block. In all cases in which depolarization block was observed, dopamine cell firing was reinstated by either iontophoretic application of gamma-aminobutyric acid or intravenous administration of apomorphine. In parallel studies, haloperidol caused an increase in the extracellular dopamine levels measured by microdialysis in the striatum of control rats, whereas administration of the same dose of haloperidol to 6-hydroxydopamine-treated rats four to six weeks postlesion did not elicit any change in extracellular dopamine levels. In addition, administration of haloperidol at a dose which was ineffective in control rats produced gross motor deficits in the 6-hydroxydopamine-treated rats when tested four to six weeks postlesion. These results show that 6-hydroxydopamine-induced dopamine depletions produce a time-dependent change in the responsivity of the nigrostriatal dopamine system to acute haloperidol administration. In this altered system, the induction of depolarization block of spike activity in nigral dopamine neurons by haloperidol was not associated with a corresponding decrease in extracellular dopamine levels measured in the striatum. However, it appeared that depolarization block did prevent haloperidol-induced increases in extracellular dopamine levels. The occurrence of depolarization block in the dopamine-depleted animal may limit the capacity of this system to respond to additional compromise, in spite of the compensatory processes that contribute to maintaining motor function.

[1]  B. Scatton Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. , 1977, European journal of pharmacology.

[2]  M. Ticku,et al.  GABAergic supersensitivity within the pars reticulata of the rat substantia nigra following chronic haloperidol administration , 1987, Brain Research.

[3]  John M. Davis,et al.  Neuroleptics: Clinical Use in Psychiatry , 1978 .

[4]  A. Grace,et al.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization , 1983, Neuroscience.

[5]  L. Coyne,et al.  Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. , 1977, Archives of general psychiatry.

[6]  J. Salamone,et al.  Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions , 1990, Neuroscience.

[7]  D. Tarsy Neuroleptic‐Induced Extrapyramidal Reactions: Classification, Description, and Diagnosis , 1983, Clinical neuropharmacology.

[8]  J. Hollerman,et al.  The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons , 1990, Brain Research.

[9]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[10]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[11]  P. Soares-da-Silva,et al.  A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: Implications for the origin of dopac , 1990, Neuropharmacology.

[12]  F. J. White,et al.  Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. , 1983, Life sciences.

[13]  R. Romo,et al.  In vivo presynaptic control of dopamine release in the cat caudate nucleus—I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei , 1986, Neuroscience.

[14]  J. Penney,et al.  γ‐Aminobutyric Acid and Benzodiazepine Receptor Changes Induced by Unilateral 6‐Hydroxydopamine Lesions of the Medial Forebrain Bundle , 1985, Journal of neurochemistry.

[15]  T. Berger,et al.  Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: Relation to behavioral recovery , 1986, Brain Research.

[16]  M. L. Pucak,et al.  Partial dopamine depletions result in an enhanced sensitivity of residual dopamine neurons to apomorphine , 1991, Synapse.

[17]  R. Roth,et al.  Release of monoamines from the striatum and hypothalamus: Effect of γ‐hydroxybutyrate , 1972, British journal of pharmacology.

[18]  K. Gale Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra , 1980, Nature.

[19]  G. Gessa,et al.  (—)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats , 1983, Brain Research.

[20]  J. Taguchi,et al.  Functional alterations in striatal cholinergic and striato-nigral gabaergic neurons following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration , 1990, Neurochemistry International.

[21]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[22]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.

[23]  E. Abercrombie,et al.  Differential Effect of Stress on In Vivo Dopamine Release in Striatum, Nucleus Accumbens, and Medial Frontal Cortex , 1989, Journal of neurochemistry.

[24]  H. Kita,et al.  Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with the PHA‐L method , 1987, The Journal of comparative neurology.

[25]  A. Guidotti,et al.  Effects of neuroleptics on striatal tyrosine hydroxylase: changes in affinity for the pteridine cofactor , 1974 .

[26]  B. Hoebel,et al.  Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis , 1989, Brain Research Bulletin.

[27]  J. Commissiong,et al.  Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle , 1990, British journal of pharmacology.

[28]  H. Meltzer,et al.  The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. , 1990, European journal of pharmacology.

[29]  B. Bunney,et al.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  A. Grace,et al.  Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. , 1978, Life sciences.

[31]  A. Carlsson,et al.  Regulation of monoamine metabolism in the central nervous system. , 1972, Pharmacological reviews.

[32]  U. Ungerstedt,et al.  In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. , 1988, European journal of pharmacology.

[33]  E. Abercrombie,et al.  Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies , 1990, Brain Research.

[34]  T. Crow,et al.  MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA , 1978, The Lancet.

[35]  J. Bourguignon,et al.  Extracellular Events Induced by γ‐Hydroxybutyrate in Striatum: A Microdialysis Study , 1991 .

[36]  C. Altar,et al.  Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats , 1984, Neuropharmacology.

[37]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  A. Friedhoff,et al.  Clinical implications of receptor sensitivity modification. , 1983, Annual review of neuroscience.

[39]  R. Roth,et al.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.

[40]  A. Grace,et al.  Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. , 1980, Science.

[41]  A. Carlsson,et al.  Evidence for a receptor‐mediated feedback control of striatal tyrosine hydroxylase activity , 1972, The Journal of pharmacy and pharmacology.

[42]  M. Zigmond,et al.  Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. , 1977, The Journal of pharmacology and experimental therapeutics.

[43]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[44]  W. Lovenberg,et al.  Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover. , 1977, Science.

[45]  G. Gessa,et al.  Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats , 1984, Brain Research.

[46]  M. Ticku,et al.  Chronic haloperidol administration increases GABA binding and enhances neuronal responsiveness to iontophoresed GABA in rat globus pallidus , 1989, Brain Research.

[47]  S. Greenfield,et al.  The effects of gamma-hydroxybutyrate on the membrane properties of guinea-pig pars compacta neurons in the substantia nigra in vitro , 1989, Neuroscience.

[48]  C. Blaha,et al.  Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: Depolarization block as a possible mechanism of action , 1987, Brain Research Bulletin.

[49]  A. Grace,et al.  Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity , 1985, Brain Research.

[50]  P. Teitelbaum,et al.  A comparison of the eating in response to hypothermic and glucoprivic challenges after nigral 6-hydroxydopamine and lateral hypothalamic electrolytic lesions in rats. , 1973, Brain research.

[51]  A. Grace,et al.  Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. , 1986, The Journal of pharmacology and experimental therapeutics.

[52]  T. Engber,et al.  Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration , 1990, Brain Research.

[53]  U. Ungerstedt Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[54]  E. Abercrombie,et al.  Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: Pharmacological and behavioral studies , 1988, Neuroscience.

[55]  J. Girault,et al.  Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats , 1986, Brain Research Bulletin.

[56]  A. Grace,et al.  Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. , 1979, European journal of pharmacology.

[57]  S. Cooper,et al.  The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia , 1990, Schizophrenia Research.

[58]  P. Teitelbaum,et al.  Nigrostriatal bundle damage and the lateral hypothalamic syndrome. , 1974, Journal of comparative and physiological psychology.

[59]  T. Crow,et al.  Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication , 1978, Psychological Medicine.

[60]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[61]  R. Roth,et al.  Regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment , 1978, Brain Research.

[62]  R. Roth,et al.  Effect of impulse flow on the release and synthesis of dopamine in the striatum , 1973 .

[63]  R. Roth,et al.  Effect of γ‐hydroxybutyrate on the release of monoamines from the rat striatum , 1972, British journal of pharmacology.

[64]  C. Marsden,et al.  The effect of chronic neuroleptic administration on cerebral dopamine receptor function. , 1983, Life sciences.

[65]  M. Zigmond,et al.  Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. , 1984, Archives of neurology.

[66]  J. Hollerman,et al.  Acute haloperidol administration induces depolarization block of nigral dopamine neurons in rats after partial dopamine lesions , 1989, Neuroscience Letters.

[67]  T. Berger,et al.  Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: Histochemical and neurochemical analysis , 1986, Brain Research.

[68]  G. Di Chiara,et al.  Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[69]  E. Gardner,et al.  Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block , 1991, Neuroscience Letters.

[70]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: single spike firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  E. Stricker,et al.  Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats , 1972, Science.

[72]  H. Meltzer,et al.  Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment , 1990, Brain Research.

[73]  H. Kita,et al.  Intracellular study of rat substantia nigra pars reticulata neurons in an in vitro slice preparation: electrical membrane properties and response characteristics to subthalamic stimulation , 1987, Brain Research.

[74]  T. Robinson,et al.  Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. , 1990, Canadian journal of psychology.

[75]  J. Bartko,et al.  Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II , 1988, Annals of neurology.

[76]  M. Zigmond,et al.  Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions , 1973, Science.

[77]  G. Sedvall,et al.  Imaging of neurotransmitter receptors in the living human brain. , 1986, Archives of general psychiatry.

[78]  A. Grace,et al.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—2. Action potential generating mechanisms and morphological correlates , 1983, Neuroscience.